
Gary B. Nickol
Examiner (ID: 7592)
| Most Active Art Unit | 1642 |
| Art Unit(s) | OPT, 1643, 1646, 1642, 1645 |
| Total Applications | 517 |
| Issued Applications | 160 |
| Pending Applications | 177 |
| Abandoned Applications | 180 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16657412
[patent_doc_number] => 20210054048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => RAPID AND SIMPLE PURIFICATION OF ELASTIN-LIKE POLYPEPTIDES DIRECTLY FROM WHOLE CELLS AND CELL LYSATES BY ORGANIC SOLVENT EXTRACTION
[patent_app_type] => utility
[patent_app_number] => 16/975431
[patent_app_country] => US
[patent_app_date] => 2019-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13453
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16975431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/975431 | RAPID AND SIMPLE PURIFICATION OF ELASTIN-LIKE POLYPEPTIDES DIRECTLY FROM WHOLE CELLS AND CELL LYSATES BY ORGANIC SOLVENT EXTRACTION | Feb 24, 2019 | Pending |
Array
(
[id] => 17922826
[patent_doc_number] => 11466059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Modified protein
[patent_app_type] => utility
[patent_app_number] => 15/733350
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 22
[patent_no_of_words] => 11891
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733350
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/733350 | Modified protein | Jan 8, 2019 | Issued |
Array
(
[id] => 16362450
[patent_doc_number] => 20200319201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => METHODS FOR MONITORING TUBERCULOSIS MEDICATION
[patent_app_type] => utility
[patent_app_number] => 16/955503
[patent_app_country] => US
[patent_app_date] => 2018-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/955503 | METHODS FOR MONITORING TUBERCULOSIS MEDICATION | Dec 17, 2018 | Abandoned |
Array
(
[id] => 16673429
[patent_doc_number] => 20210062192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => IMMUNOSTIMULATORY OLIGONUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/771789
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771789
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771789 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES | Dec 6, 2018 | Abandoned |
Array
(
[id] => 16899041
[patent_doc_number] => 20210177957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/769874
[patent_app_country] => US
[patent_app_date] => 2018-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58196
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16769874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/769874 | COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF | Dec 3, 2018 | Abandoned |
Array
(
[id] => 17458597
[patent_doc_number] => 20220071901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => A LIQUID FORMULATION OF HUMANIZED ANTIBODY FOR TREATING IL-6-MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/337372
[patent_app_country] => US
[patent_app_date] => 2018-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337372 | A LIQUID FORMULATION OF HUMANIZED ANTIBODY FOR TREATING IL-6-MEDIATED DISEASES | Nov 29, 2018 | Abandoned |
Array
(
[id] => 16762618
[patent_doc_number] => 20210108199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => Treatment for aggressive cancers by targeting C9ORF72
[patent_app_type] => utility
[patent_app_number] => 16/644844
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644844 | Treatment for aggressive cancers by targeting C9ORF72 | Sep 5, 2018 | Abandoned |
Array
(
[id] => 16009237
[patent_doc_number] => 20200179461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES
[patent_app_type] => utility
[patent_app_number] => 16/631772
[patent_app_country] => US
[patent_app_date] => 2018-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631772
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631772 | AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES | Jul 17, 2018 | Abandoned |
Array
(
[id] => 16108511
[patent_doc_number] => 20200206278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 16/631775
[patent_app_country] => US
[patent_app_date] => 2018-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631775
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/631775 | AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION | Jul 17, 2018 | Abandoned |
Array
(
[id] => 16111659
[patent_doc_number] => 20200207852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/620275
[patent_app_country] => US
[patent_app_date] => 2018-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620275 | T CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR | Jun 6, 2018 | Pending |
Array
(
[id] => 13371627
[patent_doc_number] => 20180237354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => COMPETITIVE AND EFFECTIVE BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 15/955103
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15955103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/955103 | COMPETITIVE AND EFFECTIVE BACTERIAL STRAINS | Apr 16, 2018 | Abandoned |
Array
(
[id] => 10912802
[patent_doc_number] => 20140315820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'High-Potency Botulinum Toxin Formulations'
[patent_app_type] => utility
[patent_app_number] => 14/225011
[patent_app_country] => US
[patent_app_date] => 2014-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29841
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14225011
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/225011 | High-Potency Botulinum Toxin Formulations | Mar 24, 2014 | Abandoned |
Array
(
[id] => 10279969
[patent_doc_number] => 20150164966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'SAPONIFIED TALL OIL FATTY ACID FOR USE IN TREATMENT AND ANIMAL FEED SUPPLEMENTS AND COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/401242
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4021
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14401242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/401242 | SAPONIFIED TALL OIL FATTY ACID FOR USE IN TREATMENT AND ANIMAL FEED SUPPLEMENTS AND COMPOSITIONS | May 13, 2013 | Abandoned |
Array
(
[id] => 8975978
[patent_doc_number] => 20130209408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-15
[patent_title] => 'BACTERIOPHAGE-CONTAINING THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/757655
[patent_app_country] => US
[patent_app_date] => 2013-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12907
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13757655
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/757655 | Bacteriophage-containing therapeutic agents | Jan 31, 2013 | Issued |
Array
(
[id] => 8239880
[patent_doc_number] => 20120148623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'VACCINATION FOR LAWSONIA INTRACELLULARIS'
[patent_app_type] => utility
[patent_app_number] => 13/400839
[patent_app_country] => US
[patent_app_date] => 2012-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9384
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13400839
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/400839 | VACCINATION FOR LAWSONIA INTRACELLULARIS | Feb 20, 2012 | Abandoned |
Array
(
[id] => 6431605
[patent_doc_number] => 20100143412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'BASB027 PROTEINS AND GENES FROM MORAXELLA CATARRHALIS, ANTIGENS, ANTIBODIES, AND USES'
[patent_app_type] => utility
[patent_app_number] => 12/621280
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 20053
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143412.pdf
[firstpage_image] =>[orig_patent_app_number] => 12621280
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/621280 | BASB027 PROTEINS AND GENES FROM MORAXELLA CATARRHALIS, ANTIGENS, ANTIBODIES, AND USES | Nov 17, 2009 | Abandoned |
Array
(
[id] => 5485027
[patent_doc_number] => 20090274792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Novel bacterial phytases and method for producing same'
[patent_app_type] => utility
[patent_app_number] => 12/457956
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13319
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274792.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457956
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457956 | Novel bacterial phytases and method for producing same | Jun 25, 2009 | Abandoned |
Array
(
[id] => 6371861
[patent_doc_number] => 20100075424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR GENETICALLY ENGINEERING CLOSTRIDIA SPECIES'
[patent_app_type] => utility
[patent_app_number] => 12/437985
[patent_app_country] => US
[patent_app_date] => 2009-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12644
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075424.pdf
[firstpage_image] =>[orig_patent_app_number] => 12437985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/437985 | METHODS AND COMPOSITIONS FOR GENETICALLY ENGINEERING CLOSTRIDIA SPECIES | May 7, 2009 | Abandoned |
Array
(
[id] => 6091154
[patent_doc_number] => 20110218365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'ENGINEERED LIGHT-EMITTING REPORTER GENES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/061898
[patent_app_country] => US
[patent_app_date] => 2009-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 25496
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218365.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061898
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061898 | ENGINEERED LIGHT-EMITTING REPORTER GENES AND METHODS OF USE | Mar 10, 2009 | Abandoned |
Array
(
[id] => 6228937
[patent_doc_number] => 20100183675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Stable vaccine compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/321564
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7321
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183675.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321564
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321564 | Stable vaccine compositions and methods of use | Jan 21, 2009 | Abandoned |